Resource Library
Our leadership in TPD is propelling the field forward.
Related Resources
May 10, 2022
Non-Clinical Safety Considerations when Developing Targeted Protein Degraders
Applied Pharmaceutical Toxicology (APT) 2022
April 27, 2022
Drugging Tissue Restricted E3 Ligases for TPD-based Precision Medicine
2nd Annual Ligase Targeting Drug Development Summit
April 26, 2022
Chemically Harnessing Novel E3 Ligases Biology for Next-generation TPD Therapeutics
2nd Annual Ligase Targeting Drug Development Summit
October 28, 2021
Considerations for E3 Ligase Pairing and Screening of Immune-Inflammation Targets
4th Annual TPD Summit
October 27, 2021
Understanding PK/PD for Development of STAT3 Degraders in Oncology Indications
4th Annual TPD Summit
Liquid Tumors
Solid Tumors
Read More
September 15, 2021
Inventing New Medicines with Targeted Protein Degradation
Undruggable Leaders Forum
May 26, 2021
Drugging Tissue-Restricted E3 Ligases
Ligase Targeting Drug Development Summit
February 16, 2021
Targeted Protein Degradation in Oncology and Beyond
2nd Annual North American Protein Degradation Congress
October 15, 2020
Targeted Protein Degradation Beyond Oncology
3rd Annual Targeted Protein Degradation (TPD) Summit, Dr. Mainolfi
October 14, 2020
PK/PD Relationship in Targeted Protein Degradation
3rd Annual Targeted Protein Degradation (TPD) Summit, Dr. Rong